Target intelligence / Profile preview

37 kDa laminin receptor precursor (RPSA) (RPSA)

Target
RPSA
Molecular classification
Receptor, Ribosomal protein, Cell adhesion molecule
01

Overview

The 37 kDa laminin receptor precursor (37LRP), also known as the immature laminin receptor or 37 kDa oncofetal antigen (OFA/iLRP), is a multifunctional protein encoded by the RPSA gene [1]. It exists in two main forms: a 37 kDa cytoplasmic precursor and a 67 kDa mature membrane-bound form (67LR), which acts as a high-affinity receptor for laminin in the extracellular matrix [2]. Beyond its role in cell adhesion and migration, the protein is an integral component of the 40S ribosomal subunit, where it facilitates protein synthesis and ribosome biogenesis [1]. In clinical oncology, this receptor is frequently overexpressed on the surface of various malignant cells, including breast, lung, and colon cancers, where it correlates with increased metastatic potential and poor patient prognosis [4]. It also serves as a critical entry receptor for several human pathogens, including the cellular prion protein (PrPc) and various viruses such as Dengue and Sindbis [3]. Therapeutic targeting of the receptor involves the use of monoclonal antibodies or small molecules like epigallocatechin gallate (EGCG) to inhibit its interaction with laminin or pathogens [4]. However, the ubiquitous nature of its ribosomal function presents a significant challenge for achieving high therapeutic selectivity [2].

Other names
37 kDa oncofetal antigenImmature laminin receptor protein67 kDa laminin receptorRibosomal protein SALAMR1LBPp40
02

Mechanism of action

Inhibition of laminin-receptor interaction and modulation of intracellular signaling pathways [2][4].

03

Biological functions

Cell adhesionProtein synthesisCell migrationSignal transductionRibosome assembly
04

Disease associations

CancerInfectionNeurodegenerative disease
05

Safety considerations

Potential for systemic toxicity due to the protein's essential role in the 40S ribosomal subunit and protein translation [1][2].
06

Interacting drugs

Epigallocatechin gallate

2 more in the full profile.

07

Biomarkers

RPSA overexpression67LR surface expression

Beyond the preview

Go deeper on 37 kDa laminin receptor precursor (RPSA) (RPSA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 37 kDa laminin receptor precursor (RPSA) (RPSA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call